DR. MADAUS & CO. – Trademark Portfolio

Entity Type: 99

DR. MADAUS & CO. holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 15 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes.

17 Total Trademarks

Add to watchlist:

No watchlists yet

+ Create New Watchlist

All (17) Abandoned (1) Cancelled (16)

Sort by:

By Date

By Name

Filter by Class:

Cancelled 1985

Abandoned 1985

Cancelled 1985

Cancelled 1984

Cancelled 1983

Cancelled 1983

Cancelled 1981

Cancelled 1981

Cancelled 1980

Cancelled 1978

Cancelled 1974

Cancelled 1974

Cancelled 1969

Cancelled 1966

M MADAUS

Cancelled 1966

PROVENO

Cancelled 1963

REPARIL

Cancelled 1962

Trademark Classifications

DR. MADAUS & CO.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

Pharmaceuticals (15 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Housewares (1 filing)

Household or kitchen utensils and containers; combs and sponges; brushes

Frequently Asked Questions

How many trademarks does DR. MADAUS & CO. have?

DR. MADAUS & CO. has 17 U.S. trademarks filed with the USPTO.

What trademark classes does DR. MADAUS & CO. file in?

DR. MADAUS & CO. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 21 (Housewares). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is DR. MADAUS & CO.'s trademark registration success rate?

DR. MADAUS & CO. has a 0% trademark registration rate, with 0 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.